Skip to content

NUTRALYS® Pea Protein Oral Supplementation Effects on Muscle Mass

Controlled, Randomized, Parallel, Double-blind Study of the Effect of NUTRALYS® Pea Protein Supplementation Versus Whey Protein and Placebo on the Muscle Mass and Strength of Volunteers Engaged in Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02128516
Acronym
nutralys
Enrollment
150
Registered
2014-05-01
Start date
2012-01-31
Completion date
2012-08-31
Last updated
2014-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

this clinical trial would try to confirm whether NUTRALYS®, a fast pea protein with an intermediate profile, rich in leucines and other essential amino acids, can significantly enhance muscle mass gain during strength training. This study will compare the efficacy of NUTRALYS® to a reference product. If the results of the study demonstrate a significant improvement in relation to the placebo, not inferior to that of whey, NUTRALYS® could be considered as an alternative to sports nutrition products, to which many people are intolerant.

Interventions

OTHERoral powder in sachet

Sponsors

Roquette Freres
CollaboratorINDUSTRY
Nicolas Babault
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male subjects from 18 to 35 years of age: * engaged in moderate or occasional sports activity; * having given their written informed consent; * in gainful employment or a student; * in possession of a medical certificate of fitness for sports

Exclusion criteria

* Subject already engaged in regular sports or training increasing muscle strength or volume in the upper limbs and particularly the biceps brachial; * Subject engaged or having engaged in the last 6 months in weight training more than once a week; * Subject having had a muscle injury in the 3 months prior to the study; * Asthmatic subject liable to be administered corticosteroids; * Subject taking part in another trial; * Subject with a known hypersensitivity to whey or pea proteins; * Subject deprived of their freedom for administrative, medical or legal reasons or not in possession of the legal or ethical capacity to enter into a contract due to cognitive function impairment; * Subject liable not to comply with the constraints required by the protocol; * Subject not covered by health insurance; * Subject having taken in the previous month or currently taking: medication, a dietary supplement, sports drink, food for particular nutritional uses or functional foods, of any kind, liable or described as liable to increase physical performance and notably to increase muscle mass; * Subject taking anabolic protein or corticosteroid treatment; * Subject on a high-protein diet.

Design outcomes

Primary

MeasureTime frameDescription
Biceps brachial thickness measured using ultrasonography12 weeks after first ingestionbiceps muscle thickness measured in millimeter using images from ultrasonography

Secondary

MeasureTime frameDescription
Elbow flexor strength12 weeks after first ingestionElbow flexors muscle strength measured in Newton meter using a Biodex isokinetic dynamometer in concentric, eccentric and isometric conditions.
Biceps circumference12 weeks after first ingestionthe circumference of the arm in three sites (proximal, middle and distal) using a tape (centimeter)
body weight12 weeks after first ingestionBody mass in kg on a scale
tolerance12 weeks after first ingestionTolerance measured by quantifying adverse events
muscle force12 weeks after first ingestionmaximal weight lifted during an arm curl exercise (kg)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026